McGrath; in the matter of Pan Pharmaceuticals Ltd (in liq) v Australian Naturalcare Products Pty Limited (No 2) [2008] FCAFC 44

McGrath; in the matter of Pan Pharmaceuticals Ltd (in liq) v Australian Naturalcare Products Pty Limited (No 2) [2008] FCAFC 44

Although the appeal issues were sufficiently interlocking to justify the appellants paying the respondent's costs of the appeal, the respondent separately pursued and lost the duty of care issue by notice of contention. To reflect the respondent's responsibility for the separate costs of that issue and to avoid...

Source-derived case information.

Jurisdiction
Australia
Judgment Date
07 April 2008
Procedural Posture
Appeal From a Single Judge of the Federal Court of Australia / Costs After Orders Dismissing the Appeal
Outcome
The appellants were ordered to pay 85% of the respondent's costs of the appeal, such costs to be paid out of the assets of Pan Pharmaceuticals Limited (in liquidation).
Legal Topics
['costs of Appeal' 'notice of Contention' 'issue Based Costs' 'costs Payable From Assets of Company in Liquidation']
['civil Procedure' 'costs' 'insolvency'] ['costs of Appeal' 'notice of Contention' 'issue Based Costs' 'costs Payable From Assets of Company in Liquidation']

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Appeal From a Single Judge of the Federal Court of Australia / Costs After Orders Dismissing the Appeal

Legal Issues

  1. 1 ["Whether the appellants should pay all, part, or a reduced percentage of the respondent's costs of the appeal." 'Whether costs should be adjusted because the respondent raised and lost a duty of care issue by notice of contention.']

Ratio Decidendi

Although the appeal issues were sufficiently interlocking to justify the appellants paying the respondent's costs of the appeal, the respondent separately pursued and lost the duty of care issue by notice of contention. To reflect the respondent's responsibility for the separate costs of that issue and to avoid further costs assessment, the appropriate order was that the appellants pay 85% of the respondent's costs of the appeal, payable from the assets of Pan Pharmaceuticals Limited (in liquidation).

Court Disposition

The appellants were ordered to pay 85% of the respondent's costs of the appeal, such costs to be paid out of the assets of Pan Pharmaceuticals Limited (in liquidation).

Orders

  • ["The appellants pay 85% of the respondent's costs of the appeal, such costs to be paid out of the assets of Pan Pharmaceuticals Limited (in liquidation)."]